Genome-Based Drug Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1064173
  • May 2021
  • Biotechnology
  • 134 Pages
The Genome-Based Drug market research report provides an in-depth analysis of the currents trends, latest developments, scenario, market size, various drivers, restraints, and major players along with their profile details. Research report offers the historic data for year 2018 and 2019 and also provides the forecast data from year 2020 to 2028 which is based on revenue (USD Million). With the help of all these information research report helps the market participants to improve market positions. With the help of all these insights Genome-Based Drug market research report recommends a business strategy for present market participants to strengthen their position in the market.
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Illumina, Inc., Thermo Fisher Scientific, Qiagen, Eurofins Scientific, Agilent Technologies, Oxford Nanopore Technologies, F. Hoffmann-La Roche, Bio-Rad Laboratories, BGI, Danaher Corporation
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Impact Analysis
The analysis of covid-19 is based on the impact of the current pandemic situation on market scenarios. This includes impact of covid-19 outbreak on overall revenue, market segments as well as regional market. The report also puts light on detailed impact analysis by taking into consideration all the government policies imposed during the pandemic situation, temporary shutdown of manufacturing units, current state of supply chain and distributors, and its future impacts on the growth of overall market. The market study will assist user to understand the global demand and impose strategic business plans to compete with the peers.

Furthermore, the research report includes the detailed information about major players and provides the data regarding the current market scenario as well as upcoming market opportunities or challenges. Similarly, in segment report covers the types, and applications according to the countries and key regions. The research report consists the various drivers and restraints for Genome-Based Drug market along with their effects over the forecast period. Similarly, according to the region Genome-Based Drug market research report includes the study of opportunities available in the market situation.

The Genome-Based Drug market research report provides the in-depth data analysis by using the various graphs, figures, charts, and tables. Furthermore, the report provides the different business challenges which are impacting market growth in all direction.

Major Key Players for Global Genome-Based Drug Market:
The Genome-Based Drug market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Illumina, Inc., Thermo Fisher Scientific, Qiagen, Eurofins Scientific, Agilent Technologies, Oxford Nanopore Technologies, F. Hoffmann-La Roche, Bio-Rad Laboratories, BGI, Danaher Corporation

Genome-Based Drug Market Segmentation Analysis:
By Application
Oncology
Cardiovascular
Metabolic
Rare Diseases
End-User
Research Centers
Academic and Government Institutes
Pharmaceutical and Biotechnology Companies
Others

Global Genome-Based Drug Market Segmentation by Regions:
In regional analysis, Genome-Based Drug market research report provides the detailed analysis from various regions and also contains the detailed analysis of country. Along with market revenue, market value report also offers the forecast analysis for the following countries and regions. Global Genome-Based Drug market report covers the various geographical regions such as North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa. Also, various countries included are Canada, U.K., France, the U.S., Japan, China, India, and Germany and so on.

North America Region for Genome-Based Drug Market: Value and Forecast
  • U.S.
  • Canada
 Europe Region for Genome-Based Drug Market: Value and Forecast
  • UK
  • Germany
  • France
  • Rest of the Europe
 Asia Pacific Region for Genome-Based Drug Market: Value and Forecast
  • China
  • Japan
  • India
  • Rest of the Asia Pacific
 Latin America Region for Genome-Based Drug Market: Value and Forecast
  • Mexico
  • Brazil
  • Rest of the Latin America
 Middle East and Africa for Genome-Based Drug Market: Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa


Important Points Covered by Report:
  • To analyze the value of the Genome-Based Drug market, according to the key region.
  • To study the Genome-Based Drug market current trends, prospects and also their participation in the entire sector.
  • Report consists the in-depth information related to the region/countries, major key players, current trends and their analysis, product type, applications, and other background information
  • Report provides the detailed information about drivers, restraints and future scope of Genome-Based Drug market.
  • Report covers the information about historic data analysis as well as forecast period analysis.

Global Genome-Based Drug research report consist the information about overall sales and revenue during the historic and forecasted period of 2018 to 2028. Additionally, this report covers the inside and out factual examination and the market elements and requests which give an entire situation of the business.

Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Genome-Based Drug market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Genome-Based Drug market for numerous purposes such as:

    1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Genome-Based Drug market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Genome-Based Drug market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Genome-Based Drug market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Illumina, Inc.
  • Thermo Fisher Scientific
  • Qiagen
  • Eurofins Scientific
  • Agilent Technologies
  • Oxford Nanopore Technologies
  • F. Hoffmann-La Roche
  • Bio-Rad Laboratories
  • BGI
  • Danaher Corporation
  • Oncology
  • Cardiovascular
  • Metabolic
  • Rare Diseases
  • Research Centers
  • Academic and Government Institutes
  • Pharmaceutical and Biotechnology Companies
  • Others

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Genome-Based Drug Market Snapshot
          2.1.1. Global Genome-Based Drug Market By End-User,2019
               2.1.1.1.Oncology
               2.1.1.2.Cardiovascular
               2.1.1.3.Metabolic
               2.1.1.4.Rare Diseases
          2.1.2. Global Genome-Based Drug Market By End-User,2019
               2.1.2.1.Research Centers
               2.1.2.2.Academic and Government Institutes
               2.1.2.3.Pharmaceutical and Biotechnology Companies
               2.1.2.4.Others
          2.1.3. Global Genome-Based Drug Market By End-use,2019
          2.1.4. Global Genome-Based Drug Market By Geography,2019

3. Global Genome-Based Drug Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Genome-Based Drug Market Size (US$), By End-User, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By End-User, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By End-User, 2020
     4.2. Global Genome-Based Drug Market Size (US$), By End-User, 2018 – 2028

5. Global Genome-Based Drug Market Size (US$), By End-User, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By End-User, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By End-User, 2020
     5.2. Global Genome-Based Drug Market Size (US$), By End-User, 2018 – 2028

6. Global Genome-Based Drug Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Genome-Based Drug Market Size (US$), By End-use, 2018 – 2028

7. Global Genome-Based Drug Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Genome-Based Drug Market Analysis, 2018 – 2028 
          7.2.1. North America Genome-Based Drug Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Genome-Based Drug Market Size (US$), By End-User, 2018 – 2028
          7.2.3. North America Genome-Based Drug Market Size (US$), By End-User, 2018 – 2028
          7.2.4. North America Genome-Based Drug Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Genome-Based Drug Market Analysis, 2018 – 2028 
          7.3.1.  Europe Genome-Based Drug Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Genome-Based Drug Market Size (US$), By End-User, 2018 – 2028
          7.3.3. Europe Genome-Based Drug Market Size (US$), By End-User, 2018 – 2028
          7.3.4. Europe Genome-Based Drug Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Genome-Based Drug Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Genome-Based Drug Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Genome-Based Drug Market Size (US$), By End-User, 2018 – 2028
          7.4.3. Asia Pacific Genome-Based Drug Market Size (US$), By End-User, 2018 – 2028
          7.4.4. Asia Pacific Genome-Based Drug Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Genome-Based Drug Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Genome-Based Drug Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Genome-Based Drug Market Size (US$), By End-User, 2018 – 2028
          7.5.3. Latin America Genome-Based Drug Market Size (US$), By End-User, 2018 – 2028
          7.5.4. Latin America Genome-Based Drug Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Genome-Based Drug Market Analysis, 2018 – 2028 
          7.6.1.  MEA Genome-Based Drug Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Genome-Based Drug Market Size (US$), By End-User, 2018 – 2028
          7.6.3. MEA Genome-Based Drug Market Size (US$), By End-User, 2018 – 2028
          7.6.4. MEA Genome-Based Drug Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Genome-Based Drug Providers
        8.4.1 Illumina, Inc.
                8.4.1.1 Business Description
                8.4.1.2 Illumina, Inc. Geographic Operations
                8.4.1.3 Illumina, Inc. Financial Information
                8.4.1.4 Illumina, Inc. Product Positions/Portfolio
                8.4.1.5 Illumina, Inc. Key Developments
        8.4.2 Thermo Fisher Scientific
                8.4.2.1 Business Description
                8.4.2.2 Thermo Fisher Scientific Geographic Operations
                8.4.2.3 Thermo Fisher Scientific Financial Information
                8.4.2.4 Thermo Fisher Scientific Product Positions/Portfolio
                8.4.2.5 Thermo Fisher Scientific Key Developments
        8.4.3 Qiagen
                8.4.3.1 Business Description
                8.4.3.2 Qiagen Geographic Operations
                8.4.3.3 Qiagen Financial Information
                8.4.3.4 Qiagen Product Positions/Portfolio
                8.4.3.5 Qiagen Key Developments
        8.4.4 Eurofins Scientific
                8.4.4.1 Business Description
                8.4.4.2 Eurofins Scientific Geographic Operations
                8.4.4.3 Eurofins Scientific Financial Information
                8.4.4.4 Eurofins Scientific Product Positions/Portfolio
                8.4.4.5 Eurofins Scientific Key Developments
        8.4.5 Agilent Technologies
                8.4.5.1 Business Description
                8.4.5.2 Agilent Technologies Geographic Operations
                8.4.5.3 Agilent Technologies Financial Information
                8.4.5.4 Agilent Technologies Product Positions/Portfolio
                8.4.5.5 Agilent Technologies Key Developments
        8.4.6 Oxford Nanopore Technologies
                8.4.6.1 Business Description
                8.4.6.2 Oxford Nanopore Technologies Geographic Operations
                8.4.6.3 Oxford Nanopore Technologies Financial Information
                8.4.6.4 Oxford Nanopore Technologies Product Positions/Portfolio
                8.4.6.5 Oxford Nanopore Technologies Key Developments
        8.4.7 F. Hoffmann-La Roche
                8.4.7.1 Business Description
                8.4.7.2 F. Hoffmann-La Roche Geographic Operations
                8.4.7.3 F. Hoffmann-La Roche Financial Information
                8.4.7.4 F. Hoffmann-La Roche Product Positions/Portfolio
                8.4.7.5 F. Hoffmann-La Roche Key Developments
        8.4.8 Bio-Rad Laboratories
                8.4.8.1 Business Description
                8.4.8.2 Bio-Rad Laboratories Geographic Operations
                8.4.8.3 Bio-Rad Laboratories Financial Information
                8.4.8.4 Bio-Rad Laboratories Product Positions/Portfolio
                8.4.8.5 Bio-Rad Laboratories Key Developments
        8.4.9 BGI
                8.4.9.1 Business Description
                8.4.9.2 BGI Geographic Operations
                8.4.9.3 BGI Financial Information
                8.4.9.4 BGI Product Positions/Portfolio
                8.4.9.5 BGI Key Developments
        8.4.10 Danaher Corporation
                8.4.10.1 Business Description
                8.4.10.2 Danaher Corporation Geographic Operations
                8.4.10.3 Danaher Corporation Financial Information
                8.4.10.4 Danaher Corporation Product Positions/Portfolio
                8.4.10.5 Danaher Corporation Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Genome-Based Drug Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Genome-Based Drug Market Revenue, By End-User, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Genome-Based Drug Market Revenue, By End-User, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Genome-Based Drug Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Genome-Based Drug Market Revenue, By End-User, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Genome-Based Drug Market Revenue, By End-User, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Genome-Based Drug Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Genome-Based Drug Market Revenue, By End-User, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Genome-Based Drug Market Revenue, By End-User, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Genome-Based Drug Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Genome-Based Drug Market Revenue, By End-User, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Genome-Based Drug Market Revenue, By End-User, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Genome-Based Drug Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Genome-Based Drug Market Revenue, By End-User, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Genome-Based Drug Market Revenue, By End-User, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Genome-Based Drug Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Genome-Based Drug: Market Segmentation 
FIG. 2 Global Genome-Based Drug Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Genome-Based Drug Market, By End-User, 2019 (US$ Mn) 
FIG. 5 Global Genome-Based Drug Market, By End-User, 2019 (US$ Mn) 
FIG. 6 Global Genome-Based Drug Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Genome-Based Drug Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Genome-Based Drug Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Genome-Based Drug Providers, 2019
FIG. 11 Global Genome-Based Drug Market Revenue Contribution, By End-User, 2019 & 2028 (Value %) 
FIG. 12 Global Genome-Based Drug Market Revenue Contribution, By End-User, 2019 & 2028 (Value %) 
FIG. 13 Global Genome-Based Drug Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Genome-Based Drug Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Genome-Based Drug Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Genome-Based Drug Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Genome-Based Drug Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Genome-Based Drug Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Genome-Based Drug market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Genome-Based Drug Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Genome-Based Drug Market Value, By Segment1, 2018 – 2028
TABLE  North America Genome-Based Drug Market Value, By Segment2, 2018 – 2028
TABLE  North America Genome-Based Drug Market Value, By Country, 2018 – 2028
TABLE  Europe Genome-Based Drug Market Value, By Segment1, 2018 – 2028
TABLE  Europe Genome-Based Drug Market Value, By Segment2, 2018 – 2028
TABLE  Europe Genome-Based Drug Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Genome-Based Drug Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Genome-Based Drug Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Genome-Based Drug Market Value, By Country, 2018 – 2028
TABLE  Latin America Genome-Based Drug Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Genome-Based Drug Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Genome-Based Drug Market Value, By Country, 2018 – 2028
TABLE  MEA Genome-Based Drug Market Value, By Segment1, 2018 – 2028
TABLE  MEA Genome-Based Drug Market Value, By Segment2, 2018 – 2028
TABLE  MEA Genome-Based Drug Market Value, By Country, 2018 – 2028
TABLE  Illumina, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Thermo Fisher Scientific: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Qiagen: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Eurofins Scientific: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Agilent Technologies: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Oxford Nanopore Technologies: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  F. Hoffmann-La Roche: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Bio-Rad Laboratories: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  BGI: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Danaher Corporation: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Genome-Based Drug Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Genome-Based Drug Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Genome-Based Drug Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Genome-Based Drug Market, By Geography, 2019 (US$ Mn)
FIG.  Global Genome-Based Drug Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Genome-Based Drug Providers, 2016
FIG.  Global Genome-Based Drug Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Cardiovascular Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Metabolic Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Rare Diseases Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Genome-Based Drug Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Academic and Government Institutes Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Pharmaceutical and Biotechnology Companies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Genome-Based Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Genome-Based Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Genome-Based Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Genome-Based Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Genome-Based Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Genome-Based Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Genome-Based Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Genome-Based Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Genome-Based Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Genome-Based Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Genome-Based Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Genome-Based Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Genome-Based Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Genome-Based Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Genome-Based Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Genome-Based Drug Market Value, 2018 – 2028, (US$ Mn)